2022 Honorees
2022 Honorees
NKF Honor - Excellence in Nephrology
Daniel L. Landry, DO, FASN
Chief, Division of Nephrology
Medical Director, Inpatient Dialysis and Critical Care Nephrology Baystate Medical Center
Assistant Professor of Medicine, University of Massachusetts Medical School-Baystate
Dr. Landry serves as the Chief of the Division of Nephrology as well as the Medical Director of Acute Inpatient Dialysis and Critical Care Nephrology at Baystate Medical Center, the only tertiary care medical center serving Western Massachusetts. Since his completion of service in the US Navy and subsequent arrival at Baystate Medical Center, Dr. Landry has been recognized by colleagues and trainees as a valuable educator, having twice won the Baystate Internal Medicine Department’s Martin I. Brodeur teacher of the year award for excellence in fellowship education. He is also the medical director for the in-center and home dialysis program at FKC East Springfield and a member of the only ESRD Seamless Care Organization in New England, now beginning its transition to the voluntary value-based payment model known as Kidney Care First in January 2022. With a passion for health care delivery innovations and support, Dr. Landry also serves as chair of the medical review board for the End Stage Renal Disease Network of New England (ESRD Network 1) and is New England regional representative to the National Forum of ESRD Networks, both voluntary organizations that focus on improving patient advocacy as well as the overall quality of dialysis care. His most recent health care delivery efforts have focused on addressing COVID-19 vaccine hesitancy in dialysis patients, supporting national education of providers and patients alike through the Forum’s toolkits, and advancing the use of nephrology advanced practitioners to improve fellowship education as well as continuity of care of dialysis patients.
Medical Director, Inpatient Dialysis and Critical Care Nephrology Baystate Medical Center
Assistant Professor of Medicine, University of Massachusetts Medical School-Baystate
Dr. Landry serves as the Chief of the Division of Nephrology as well as the Medical Director of Acute Inpatient Dialysis and Critical Care Nephrology at Baystate Medical Center, the only tertiary care medical center serving Western Massachusetts. Since his completion of service in the US Navy and subsequent arrival at Baystate Medical Center, Dr. Landry has been recognized by colleagues and trainees as a valuable educator, having twice won the Baystate Internal Medicine Department’s Martin I. Brodeur teacher of the year award for excellence in fellowship education. He is also the medical director for the in-center and home dialysis program at FKC East Springfield and a member of the only ESRD Seamless Care Organization in New England, now beginning its transition to the voluntary value-based payment model known as Kidney Care First in January 2022. With a passion for health care delivery innovations and support, Dr. Landry also serves as chair of the medical review board for the End Stage Renal Disease Network of New England (ESRD Network 1) and is New England regional representative to the National Forum of ESRD Networks, both voluntary organizations that focus on improving patient advocacy as well as the overall quality of dialysis care. His most recent health care delivery efforts have focused on addressing COVID-19 vaccine hesitancy in dialysis patients, supporting national education of providers and patients alike through the Forum’s toolkits, and advancing the use of nephrology advanced practitioners to improve fellowship education as well as continuity of care of dialysis patients.
NKF Honor – Excellence in Transplant and Nephrology
Jean Francis, MD
Medical Director of Kidney Transplantation
Boston University Medical Center
Associate Professor of Medicine
Boston University School of Medicine
Medical Director of Pancreas Transplant Program, Brigham and Women Hospital
Associate Physician Brigham and Women Hospital
Dr. Francis obtained his medical degree from the Lebanese University School of Medicine. He completed his medicine residency and nephrology fellowship at Yale University- Saint Raphael Campus. He subsequently did kidney and pancreas transplantation fellowship at Beth Israel Deaconess Medical Center and Harvard Medical School. He is currently the Medical Director of kidney transplantation at BUMC, and serves as the Medical Director of the combined Pancreas Transplant Program between BUMC and BWH. This is a combined program between the two institutions that facilitates the cure of type 1 & 2 DM with pancreas transplantation in very selected patients. Dr. Francis conducts clinical research in kidney transplantation, and has a special interest in thrombotic microangiopathy and complement-mediated diseases. He is also an accomplished educator who has won several excellence in teaching awards. Dr. Francis serves as a Co-Director of BU’s Thrombosis and Microangiopathy Collaborative, he is also a co-director of the ARC on Thrombosis and Homeostasis. He serves as the region one UNOS representative for Pancreas transplantation.
Thrombotic microangiopathy (TMA) is a rare but very serious condition. Dr. Francis is the founder of the first Thrombotic Microangiopathy (TMA) Team at Boston Medical Center (BMC), a unique multidisciplinary approach to the management of this very rare disease. Many institutions and medical centers in the US and around the world currently adopt this model to care for patients with TMA.
Dr. Francis is nationally recognized clinician-educator, a frequent invited speaker; he has published > 60 scientific manuscripts, reviews and book chapters. He has also trained many nephrologists.
Boston University Medical Center
Associate Professor of Medicine
Boston University School of Medicine
Medical Director of Pancreas Transplant Program, Brigham and Women Hospital
Associate Physician Brigham and Women Hospital
Dr. Francis obtained his medical degree from the Lebanese University School of Medicine. He completed his medicine residency and nephrology fellowship at Yale University- Saint Raphael Campus. He subsequently did kidney and pancreas transplantation fellowship at Beth Israel Deaconess Medical Center and Harvard Medical School. He is currently the Medical Director of kidney transplantation at BUMC, and serves as the Medical Director of the combined Pancreas Transplant Program between BUMC and BWH. This is a combined program between the two institutions that facilitates the cure of type 1 & 2 DM with pancreas transplantation in very selected patients. Dr. Francis conducts clinical research in kidney transplantation, and has a special interest in thrombotic microangiopathy and complement-mediated diseases. He is also an accomplished educator who has won several excellence in teaching awards. Dr. Francis serves as a Co-Director of BU’s Thrombosis and Microangiopathy Collaborative, he is also a co-director of the ARC on Thrombosis and Homeostasis. He serves as the region one UNOS representative for Pancreas transplantation.
Thrombotic microangiopathy (TMA) is a rare but very serious condition. Dr. Francis is the founder of the first Thrombotic Microangiopathy (TMA) Team at Boston Medical Center (BMC), a unique multidisciplinary approach to the management of this very rare disease. Many institutions and medical centers in the US and around the world currently adopt this model to care for patients with TMA.
Dr. Francis is nationally recognized clinician-educator, a frequent invited speaker; he has published > 60 scientific manuscripts, reviews and book chapters. He has also trained many nephrologists.
NKF Honor – Excellence in Renal Pathology
Helmut G. Rennke, MD
Director, Renal Pathology
Professor, Harvard Medical School
Pathology
Helmut G. Rennke, MD, is professor of pathology at Harvard Medical School and director of the renal pathology and electron microscopy laboratory at Brigham and Women's Hospital in Boston. He obtained his MD from the University of Chile Medical School followed by an internship and residency in pathology at Hospital del Salvador in Santiago. He then completed a fellowship in pathology at the University of Kiel in Germany, residencies at the Mallory Institute of Pathology at Boston City Hospital and at the Peter Bent Brigham Hospital, and a research fellowship in pathology under Manjeri Venkatachalam and Ramzi S. Cotran. He has remained in the Department of Pathology what is now the Brigham and Women's Hospital in Boston.
His early experimental research focused on various pathophysiological aspects of disease of the kidney, in particular the molecular determinants of the permeability of macromolecular transport across the glomerular capillary wall. These studies revealed that the molecular charge and configuration, in addition to size, are key factors in the glomerular permeability to proteins and important determinants for the localization of antigens within the glomerular capillary wall and the clinical and structural expression of immune complex-mediated glomerular diseases. In a large series of experimental studies on renal ablation done in collaboration with members of micropuncture laboratory headed by Barry Brenner, this group showed that the progression of chronic kidney disease is in part due to compensatory structural and hemodynamic adaptations and podocyte hypertrophy that are part of a positive-feedback loop that results in obsolescence of filtering capillaries and irreversible focal and segmental and eventually global glomerulosclerosis. Additional experimental studies on acute kidney failure established the relevance of vasoconstriction in the initiation and maintenance of acute tubular necrosis.
He has been teaching renal pathophysiology at Harvard Medical School and at the Harvard-MIT Program on Health Sciences and Technology since the late '70s and renal pathology and pathophysiology at various post-graduate courses for nephrologists since the 1980's. As director of the Renal Pathology Fellowship Program he has participated in the training of more than 50 renal pathologist from the US and abroad and many generations of nephrology fellows. He has been the recipient of the Jacob Churg Award from the Renal Pathology Society and the Premio Victor R Miatello of the Latin American Society of Nephrology and Hypertension.
Professor, Harvard Medical School
Pathology
Helmut G. Rennke, MD, is professor of pathology at Harvard Medical School and director of the renal pathology and electron microscopy laboratory at Brigham and Women's Hospital in Boston. He obtained his MD from the University of Chile Medical School followed by an internship and residency in pathology at Hospital del Salvador in Santiago. He then completed a fellowship in pathology at the University of Kiel in Germany, residencies at the Mallory Institute of Pathology at Boston City Hospital and at the Peter Bent Brigham Hospital, and a research fellowship in pathology under Manjeri Venkatachalam and Ramzi S. Cotran. He has remained in the Department of Pathology what is now the Brigham and Women's Hospital in Boston.
His early experimental research focused on various pathophysiological aspects of disease of the kidney, in particular the molecular determinants of the permeability of macromolecular transport across the glomerular capillary wall. These studies revealed that the molecular charge and configuration, in addition to size, are key factors in the glomerular permeability to proteins and important determinants for the localization of antigens within the glomerular capillary wall and the clinical and structural expression of immune complex-mediated glomerular diseases. In a large series of experimental studies on renal ablation done in collaboration with members of micropuncture laboratory headed by Barry Brenner, this group showed that the progression of chronic kidney disease is in part due to compensatory structural and hemodynamic adaptations and podocyte hypertrophy that are part of a positive-feedback loop that results in obsolescence of filtering capillaries and irreversible focal and segmental and eventually global glomerulosclerosis. Additional experimental studies on acute kidney failure established the relevance of vasoconstriction in the initiation and maintenance of acute tubular necrosis.
He has been teaching renal pathophysiology at Harvard Medical School and at the Harvard-MIT Program on Health Sciences and Technology since the late '70s and renal pathology and pathophysiology at various post-graduate courses for nephrologists since the 1980's. As director of the Renal Pathology Fellowship Program he has participated in the training of more than 50 renal pathologist from the US and abroad and many generations of nephrology fellows. He has been the recipient of the Jacob Churg Award from the Renal Pathology Society and the Premio Victor R Miatello of the Latin American Society of Nephrology and Hypertension.
Covid Leadership Award
NKF Honors Special Award- COVID Leadership: A special recognition of the leaders and organizations that came together as one powerful entity to care for chronically ill kidney patients during the pandemic. They worked tirelessly to share resources, expertise, information, and supplies in order to provide critical services for dialysis patients and to keep them safe. During these most difficult times they collaborated, supported, and communicated in an unprecedented way. We honor them for all that they accomplished in this most difficult time.
Awardees include:
Mark Caputo, .Chairman and CEO, US Renal Care
Doug Johnson, MD, Vice Chair, DCI
Nick Mendez, CEO, American Renal Associates
Rice Powell, CEO and Chairman, Fresenius Medical Care
Javier Rodriguez, CEO, Davita, Inc
Bill Valle, CEO, Fresenius Medical Care North America
Community Partnership Award
Akebia Therapeutics
This award recognizes an organization for outstanding collaboration and innovative partnership with the NKF to benefit the kidney community.
Sponsors
Sponsors
Today's events would not be possible without the help and generosity of our sponsors!
Gold Sponsor
Bronze Sponsor
Hospital Sponsor
